
Validea's guru fundamental report assigns UNITEDHEALTH GROUP INC (UNH), a large-cap insurance growth stock, a 77% rating under Martin Zweig's Growth Investor model. This score, which seeks accelerating earnings and sales growth with reasonable valuations, indicates UNH passes on metrics like P/E and current quarter earnings but fails on revenue growth relative to EPS and consistency in past earnings growth, placing it below the 80% threshold for 'some interest' according to the strategy.
UnitedHealth Group (UNH) receives a 77% rating from Validea's Growth Investor model, which is based on the strategy of Martin Zweig. This score positions the stock as a borderline candidate, as it falls just below the 80% threshold that typically indicates model interest. The analysis reveals a mixed fundamental picture: UNH demonstrates strength in its valuation, passing the P/E ratio test, and shows positive current-quarter earnings momentum, with EPS growth accelerating over the prior three quarters. The model also registers favorable insider transaction activity and positive long-term EPS growth. However, several key criteria for a high-conviction growth stock are not met. The model flags that UNH's revenue growth is not keeping pace with its EPS growth, and that the earnings growth rate over the past several quarters has been inconsistent. Furthermore, while current EPS growth is strong, it fails to exceed the company's historical growth rate, suggesting a potential deceleration from its long-term trend rather than a new phase of acceleration.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment